SCHEMBL6948645

SCHEMBL6948645

CC1=NN(c2ccc(S(=O)(=O)N3CCN(C)CC3)cc2)C(=O)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.54
ALDH1A1 P00352 5/20 0.54
MAPT P10636 5/20 0.54
MEN1 O00255 4/20 0.54
TDP1 Q9NUW8 2/20 0.54
LMNA P02545 2/20 0.54
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.52
KDM4E B2RXH2 2/20 0.52
TSHR P16473 2/20 0.52
GAA P10253 2/20 0.52
CYP1A2 P05177 1/20 0.52
CHRM2 P08172 1/20 0.52
CYP3A4 P08684 1/20 0.52
CHRM1 P11229 1/20 0.52
PTGS1 P23219 1/20 0.52
DRD3 P35462 1/20 0.52
RECQL P46063 1/20 0.52
ATM Q13315 1/20 0.51
APP P05067 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948663 0.86 POLB (0.52) KMT2AALDH1A1MAPTMEN1TDP1
SCHEMBL8428161 0.85 CYP2C9 (0.51) ALDH1A1LMNATSHRATMPOLB
SCHEMBL2223232 0.80 MAPT (0.66) KMT2AALDH1A1MAPTMEN1TDP1
SCHEMBL22670497 0.79 MAPT (0.64) KMT2AALDH1A1MAPTMEN1TDP1
SCHEMBL2365087 0.77 CA1 (0.76) KMT2AALDH1A1MAPTMEN1TDP1
SCHEMBL7564728 0.76 KMT2A (0.84) KMT2AALDH1A1MEN1LMNAHTT
SCHEMBL8200020 0.76 KMT2A (0.84) KMT2AALDH1A1MEN1LMNAHTT
SCHEMBL9386579 0.76 KMT2A (0.84) KMT2AALDH1A1MEN1LMNAHTT
SCHEMBL2203669 0.75 MAPT (0.77) KMT2AALDH1A1MAPTMEN1TDP1
SCHEMBL8205136 0.72 KMT2A (0.94) KMT2AALDH1A1MEN1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed